Veterinary Medicines

Versifel CVR suspensão injetável para gatos

Authorised
  • Feline panleucopenia virus, strain Snow Leopard, Live
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain FVRm, Live
Download as PDF

Product identification

Medicine name:
Versifel CVR suspensão injetável para gatos
Active substance:
  • Feline panleucopenia virus, strain Snow Leopard, Live
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain FVRm, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain Snow Leopard, Live
    3.00
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain F9, Live
    5.50
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain FVRm, Live
    5.00
    log10 cell culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 8(3) of Directive No 2001/83/EC)
Marketing authorisation holder:
  • Zoetis Portugal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 833/10NIVPT
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 15/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."